Cyclin-dependent Kinase-5 Is a Key Molecule in Tumor Necrosis Factor-α-induced Insulin Resistance

The mechanism of TNF-alpha-induced insulin resistance has remained unresolved with evidence for down-regulation of insulin effector targets effects or blockade of proximal as well as distal insulin signaling events depending upon the dose, time, and cell type examined. To address this issue we examined the acute actions of TNF-alpha in differentiated 3T3L1 adipocytes. Acute (5-15 min) treatment with 20 ng/ml (similar to 0.8 nM) TNF-alpha had no significant effect on IRS1-associated phosphatidylinositol 3-kinase. In contrast, TNF-alpha increased insulin-stimulated cyclin-dependent kinase-5 (CDK5) phosphorylation on tyrosine residue 15 through an Erk-dependent pathway and up-regulated the expression of the CDK5 regulator protein p35. In parallel, TNF-alpha stimulation also resulted in the phosphorylation and GTP loading of the Rho family GTP-binding protein, TC10 alpha. TNF-alpha enhanced the depolymerization of cortical F-actin and inhibited insulin-stimulated glucose transporter-4 (GLUT4) translocation. Treatment with the MEK inhibitor, PD98059, blocked the TNF-alpha-induced increase in CDK5 phosphorylation and the depolymerization of cortical F-actin. Conversely, siRNA-mediated knockdown of CDK5 or treatment with the MEK inhibitor restored the impaired insulin-stimulated GLUT4 translocation induced by TNF-alpha. Furthermore, siRNA-mediated knockdown of p44/42 Erk also rescued the TNF-alpha inhibition of insulin-stimulated GLUT4 translocation. Together, these data demonstrate that TNF-alpha-mediated insulin resistance of glucose uptake can occur through a MEK/Erk-dependent activation of CDK5.